See also this year's filing and all EDGAR filings for this company.
PDF Report 0001099574_2016_Eastgate_Biotech_CORP.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001099574, Eastgate Biotech CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 113,517 |
| 1 | AssetsNonCurrent | 0 |
| 2 | remainder_Assets | 184,402 |
| 3 | LiabilitiesCurrent | 2,728,614 |
| 4 | LiabilitiesNonCurrent | 0 |
| 5 | remainder_Liabilities | 50,386 |
| 6 | GeneralAndAdministrativeExpense | 2,541,586 |
| 7 | ProfessionalFees | 137,066 |
| 8 | remainder_Expenses | 1,624,759 |
| 9 | remainder_Revenues | 132,025 |
| 10 | remainder_NetIncome | -109,924 |
| 11 | remainder_ComprehensiveNetIncome | 16,578 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 297,919 |
| 1 | Liabilities | 2,779,000 |
| 2 | Expenses | 4,303,411 |
| 3 | Revenues | 132,025 |
| 4 | StockholdersEquity | -2,481,081 |
| 5 | NetIncome | -4,281,310 |
| 6 | ComprehensiveNetIncome | -4,264,732 |
| 7 | BaseVar | 3,819,428 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -10.8 |
| 9 | EconomicCapitalRatio | 0.867 |
Edgar->Model Mapping
Feature Distribution
Change over Time
